Diligence memo · auto-generated · as of July 2, 2026
Techulon Inc
Techulon Inc looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Techulon Inc operates in Biotechnology, based in BLACKSBURG.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Techulon Inc has raised $1.4M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $800K on 2009-12-31.
Most recent recorded round closed around 2019-07-15.
Valuation (modeled)modeled
Provath models Techulon Inc at approximately $22M (range $211K–$247M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.40× the median modeled value of Pre-Seed Biotechnology companies in 2019–2021 (156 peers) — value vs value, same stage and era. Within the normal band (140% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 20 months.
Last raise 7.0 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 2.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 22% of Biotechnology peers (4293 compared).
Modeled value ranks above 30% of those peers.
Closest niche peers: Crimson BioPharm Inc., Pinpoint Therapeutics Inc., Transplant Logistics & Informatics Llc, RNAissance AG LLC, Pylum Biosciences, Inc..
Peoplefiled
16 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.